Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Huang

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Science (New York, N.Y.)|February 13, 2025
In Science JournalsJesse Smith, Di Jiang, Phil Szuromi, et al.
Science (New York, N.Y.)|May 7, 2026
In Science JournalsJesse Smith, Phil Szuromi, Michael A Funk, et al.
Science (New York, N.Y.)|August 28, 2025
In Science JournalsAngela Hessler, Bianca Lopez, Michael A Funk, et al.
Science (New York, N.Y.)|May 14, 2026
In Science JournalsSacha Vignieri, Angela Hessler, Phil Szuromi, et al.
Science (New York, N.Y.)|May 28, 2026
In Science JournalsKeith T Smith, Angela Hessler, Jack Huang, et al.
Science (New York, N.Y.)|November 13, 2025
In Science JournalsMarc Lavine, Keith T Smith, L Bryan Ray, et al.
Science (New York, N.Y.)|December 18, 2025
In Science JournalsSacha Vignieri, Yury Suleymanov, Jack Huang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 7, 2025
FURVENT: Phase 3 trial of firmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004)Alexander Spira, Byoung Chul Cho, Enriqueta Felip, et al.
Autophagy|February 26, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>Daniel J Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Science (New York, N.Y.)|February 13, 2025
In Science JournalsJesse Smith, Di Jiang, Phil Szuromi, et al.
Science (New York, N.Y.)|May 7, 2026
In Science JournalsJesse Smith, Phil Szuromi, Michael A Funk, et al.
Science (New York, N.Y.)|August 28, 2025
In Science JournalsAngela Hessler, Bianca Lopez, Michael A Funk, et al.
Science (New York, N.Y.)|May 14, 2026
In Science JournalsSacha Vignieri, Angela Hessler, Phil Szuromi, et al.
Science (New York, N.Y.)|May 28, 2026
In Science JournalsKeith T Smith, Angela Hessler, Jack Huang, et al.
Science (New York, N.Y.)|November 13, 2025
In Science JournalsMarc Lavine, Keith T Smith, L Bryan Ray, et al.
Science (New York, N.Y.)|December 18, 2025
In Science JournalsSacha Vignieri, Yury Suleymanov, Jack Huang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 7, 2025
FURVENT: Phase 3 trial of firmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004)Alexander Spira, Byoung Chul Cho, Enriqueta Felip, et al.
Autophagy|February 26, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>Daniel J Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, et al.
Pageof 4